Bayer reports drop in third-quarter net income, confirms outlook for 2012

Bayer today reported a 17.8% fall in third-quarter net income to €528 million ($682.2 million) on 11.5% higher sales at €9.67 billion. Core earnings per share advanced 7.1% to €1.20. Ebitda before special items improved 2.2% to €1.85 billion. The company confirmed earlier forecasts for the whole of 2012.    “The upward trend in our life science businesses, HealthCare and CropScience, continued in the third quarter of 2012,” says Marijn Dekkers, Bayer’s chairman. HealthCare, particularly the pharmaceuticals business...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers